Expert Opinion on the introduction of new drugs for tuberculosis control in the EU/EEA

Public health guidance

19 Mar 2015

Cite:

Take our survey

Share your feedback in our short survey and help us improve publications at ECDC. Your input is valuable!

This Expert Opinion outlines some pre-conditions that are considered to be essential at the national level prior to the use of new drugs for the treatment of tuberculosis, as well as specific conditions needed in order to successfully implement new TB drugs/regimens.

Download

Expert Opinion on the introduction of new drugs for tuberculosis control in the EU/EEA - EN - [PDF-578.52 KB]

Related content

Cover of the report: "Evidence brief: Progress towards reaching the Sustainable Development Goal 3.3 targets related to HIV, TB, viral hepatitis and sexually transmitted infections in the European Union and European Economic Area"

Evidence brief: Progress towards reaching the Sustainable Development Goal 3.3 targets related to HIV, TB, viral hepatitis and sexually transmitted infections in the European Union and European Economic Area

23 Apr 2025 - Although preventable, viral hepatitis, HIV, sexually transmitted infections (STI) and tuberculosis (TB) remain public health issues in the European Union and European Economic Area (EU/EEA), causing substantial morbidity and nearly 57 000 deaths annually.

Cover of the report: "Progress towards reaching the Sustainable Development Goal 3.3 targets related to HIV, tuberculosis, viral hepatitis and sexually transmitted infections in the EU/EEA"

Progress towards reaching the Sustainable Development Goal 3.3 related to HIV, TB, viral hepatitis and sexually transmitted infections in the EU/EEA

23 Apr 2025 - This report provides an update on progress towards the Sustainable Development Goal Target (SDG) 3.3 and other main global and regional targets for eliminating HIV, viral hepatitis, tuberculosis (TB) and sexually transmitted infections (STIs) as public health threats.

Communicable disease threats report, 22-28 March 2025, week 13

28 Mar 2025 - This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 22-28 March 2025 and includes updates on influenza A(H5N1), chikungunya, dengue, Ebola, tuberculosis and an overview of respiratory virus epidemiology in the EU/EEA.

Load More

Infectious disease topics

Spotlight

Publications and data

Spotlight

Training and tools

Spotlight

About ECDC

Spotlight

Expert Opinion on the introduction of new drugs for tuberculosis control in the EU/EEA

Download

Related content

Evidence brief: Progress towards reaching the Sustainable Development Goal 3.3 targets related to HIV, TB, viral hepatitis and sexually transmitted infections in the European Union and European Economic Area

Progress towards reaching the Sustainable Development Goal 3.3 related to HIV, TB, viral hepatitis and sexually transmitted infections in the EU/EEA

Communicable disease threats report, 22-28 March 2025, week 13

Follow us: